10x Genomics, Inc. Cash Flow Statement

Cash Flow Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -18.76M-112.48M-31.25M-542.78M-58.22M-166.00M-255.10M-182.63M
Depreciation and Depletion 4.30M3.80M6.70M12.30M18.50M22.80M32.90M33.90M
Share-based Compensation 1.66M2.66M13.33M48.63M95.96M136.85M166.95M140.75M
Gains from Investment Securities 0.79M-0.61M306.00M21.28M16.56M6.52M5.64M
Asset Writedowns and Impairment 9.85M3.05M
Cash from Operations -10.70M-76.41M34.63M-217.90M-21.37M-33.61M-15.20M6.66M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.15M0.46M0.10M5.01M7.14M7.64M8.11M7.83M
Depreciation & Amortization (CF) 4.30M3.90M7.07M14.01M21.12M25.37M35.51M35.88M
Change in Working Capital
Change in Receivables 5.13M14.75M5.28M17.85M34.04M18.95M10.61M-26.95M
Change in Inventory 2.00M3.73M6.70M14.60M30.13M21.19M-7.87M9.78M
Change in Account Payables 3.03M2.59M4.90M-7.77M11.08M5.86M-6.02M-3.35M
Change in Accured Expenses 3.50M2.60M5.77M25.92M16.34M3.34M28.30M-12.74M
Other Working Capital Changes 1.32M3.33M12.73M5.26M-4.71M-6.42M10.93M-12.48M
Investing Activities
Capital Expenditures 3.76M6.28M42.74M36.67M101.28M131.66M48.60M12.39M
Change in Intangibles 0.42M0.03M1.73M0.92M1.00M
Acquisitions 5.45M4.00M
Change in Acquisitions & Divestments 49.12M100.19M25.78M
Cash from Investing Activities -3.76M-6.71M-42.77M-38.39M-106.73M-350.89M133.49M-32.63M
Financing Activities
Other financing activities 5.85M5.03M5.41M5.81M
Cash from Financing Activities 20.58M105.37M414.59M468.91M35.30M15.82M13.67M10.91M
Additional items
Exchange Rate Effect -0.01M-0.02M-0.04M-0.46M0.23M-0.04M-0.03M-0.16M
Change in Cash 6.11M22.23M406.40M212.15M-92.57M-368.72M131.93M-15.22M
Beginning Cash Balance -6.11M42.85M17.76M451.45M680.02M588.47M227.35M359.28M
Free Cash Flow -14.46M-82.69M-8.12M-254.56M-122.65M-165.27M-63.80M-5.73M
Net Cash Flow 6.13M22.25M406.45M212.61M-92.81M-368.68M131.96M-15.05M